Vyome Holdings, Inc. (HIND)
2.242
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.19
-0.05
(-2.32%)
Pre-Market: 08:26
Vyome Holdings Total Liabilities (Quarterly) : 1.865M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.865M |
| March 31, 2026 | 2.144M |
| December 31, 2025 | 2.735M |
| September 30, 2025 | 3.127M |
| June 30, 2025 | 3.199M |
| March 31, 2025 | 5.253M |
| December 31, 2024 | 5.773M |
| September 30, 2024 | 4.128M |
| June 30, 2024 | 3.358M |
| March 31, 2024 | 3.697M |
| December 31, 2023 | 4.064M |
| September 30, 2023 | 4.744M |
| June 30, 2023 | 5.114M |
| March 31, 2023 | 8.594M |
| December 31, 2022 | 7.604M |
| September 30, 2022 | 7.513M |
| June 30, 2022 | 9.562M |
| March 31, 2022 | 8.645M |
| December 31, 2021 | 8.571M |
| September 30, 2021 | 11.48M |
| Date | Value |
|---|---|
| June 30, 2021 | 61.88M |
| March 31, 2021 | 7.245M |
| December 31, 2020 | 25.23M |
| September 30, 2020 | 6.04M |
| June 30, 2020 | 6.695M |
| March 31, 2020 | 8.157M |
| December 31, 2019 | 4.544M |
| September 30, 2019 | 4.592M |
| June 30, 2019 | 10.81M |
| March 31, 2019 | 25.85M |
| December 31, 2018 | 17.28M |
| September 30, 2018 | 16.73M |
| June 30, 2018 | 16.42M |
| March 31, 2018 | 16.08M |
| December 31, 2017 | 17.99M |
| September 30, 2017 | 15.56M |
| June 30, 2017 | 14.76M |
| March 31, 2017 | 13.52M |
| December 31, 2016 | 14.47M |
| September 30, 2016 | 15.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | 2.726M |
| Anika Therapeutics, Inc. | 46.19M |
| Enovis Corp. | 2.287B |
| Edwards Lifesciences Corp. | 3.142B |
| Perspective Therapeutics, Inc. | 68.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.176M |
| Shareholders Equity (Quarterly) | 6.048M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 4.372 |
| Net Debt Paydown Yield | 0.15% |